In CPhI s 2017 Annual Report , Girish Malhorta, CPhI expert and president of EPCOT International, took a look at revenues of pharmaceuticals around the world to get a perspective on how drug companies may be able to reduce the cost and availability of the drugs they manufacture. Malhorta beliOriginal Article
You may also like
Pharmaceutical Sales Customer Engagement –...
AstraZeneca’s Polyneuropathy Treatment Recommended...
Designing a Strategic Roadmap for Seamless Product...
AAPS PharmSci 360: LBFs and Tackling Oral Biologic...
CHMP Gives Positive Opinion to Novo Nordisk Hemophilia...
GSK, Cambridge to Partner on R&D for Kidney and...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.